VASO VASO CORPORATION Loading... : Investor Sentiment and Bull/Bear Views

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
04:13
Aug 10
r/ValueInvesting
Vaso Corporation has a market cap of $37m, which is roughly equal to its net cash position.
Vaso Corporation has a market cap of $37m, which is roughly equal to its net cash position. The market is valuing the actual operating business (a profitable GE HealthCare partnership) at less than zero. A classic net-net/deep value play where investors get a profitable, cash-generating business for free. Micro-cap illiquidity, high family control (44%), and reliance on a single exclusive contract (GE HealthCare) expiring in 2030.
VASO VASO CORPORATION Long — —
04:06
Jul 16
r/ValueInvesting
$22M cash vs $33M market cap; exclusive GE HealthCare contract generates $6-7M annually.
$22M cash vs $33M market cap; exclusive GE HealthCare contract generates $6-7M annually; management clearing two losing segments. Net cash covers two-thirds of market cap, making the profitable core contract essentially free; cleanup could unlock hidden value. Deep value play with cash backing and a catalyst from divestitures. OTC listing, low liquidity, remaining losses persist.
VASO VASO CORPORATION Long 1ST — —
17:36
Jan 30
r/ValueInvesting
Profitable nano-cap below net cash with GE HealthCare catalyst
Vaso Corporation is a profitable nano-cap trading at a market cap of ~$31M while holding ~$35M in cash and minimal debt, giving it negative enterprise value. The company generated $9.4M in free cash flow in the first nine months of 2025, about a 30% yield, and its contract with GE HealthCare has been extended to 2030 while management divests unprofitable units. The main stated risks are its OTC listing and high customer concentration with GE HealthCare.
VASO VASO CORPORATION Long 1ST — —

About VASO Investor Commentary

Across the available history and selected sources, Buzzberg tracks VASO (VASO CORPORATION) across 1 sources: 3 bullish vs 0 bearish calls from 2 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 3 total trade ideas tracked. Latest voices: u/Away_Definition5829, u/Western-Safety-8346.